Playback speed
10 seconds
ASCO 2022 Bendamustine Rituximab vs. Ibrutinib as Primary Therapy for WM: An International Collaborative Study
By
ASCO 2022 Conference Coverage
FEATURING
Jithma Abeykoon
By
ASCO 2022 Conference Coverage
FEATURING
Jithma Abeykoon
1,654 views
June 9, 2022
Login to view comments.
Click here to Login